Checkmarks in Both the 'Pro' and 'Con' Columns | GenomeWeb

The BBC speaks with 23andMe's Linda Avey and Anne Wojcicki about their company and their motivation. "The reason we started this company is that we really dramatically wanted to change healthcare," Wojcicki tells the BBC. Avey adds that they think that if people know their genetic information, they will take better care of themselves. The BBC also mentions that FDA is "warming to personal gene services," though the public still has some concerns.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.